Cell-Mediated Immune Responses to COVID-19 Infection
- PMID: 32719687
- PMCID: PMC7350607
- DOI: 10.3389/fimmu.2020.01662
Cell-Mediated Immune Responses to COVID-19 Infection
Abstract
An unprecedented outbreak of pneumonia caused by a novel coronavirus (CoV), subsequently termed COVID-19 by the World Health Organization, emerged in Wuhan City (China) in December 2019. Despite rigorous containment and quarantine efforts, the incidence of COVID-19 continues to expand, causing explosive outbreaks in more than 160 countries with waves of morbidity and fatality, leading to significant public health problems. In the past 20 years, two additional epidemics caused by CoVs have occurred: severe acute respiratory syndrome-CoV, which has caused a large-scale epidemic in China and 24 other countries; and respiratory syndrome-CoV of the Middle East in Saudi Arabia, which continues to cause sporadic cases. All of these viruses affect the lower respiratory tract and manifest as pneumonia in humans, but the novel SARS-Cov-2 appears to be more contagious and has spread more rapidly worldwide. This mini-review focuses on the cellular immune response to COVID-19 in human subjects, compared to other clinically relevant coronaviruses to evaluate its role in the control of infection and pathogenesis and accelerate the development of a preventive vaccine or immune therapies.
Keywords: COVID-19; SARS - CoV-2; adaptive immunity; coronavirus; innate immunity.
Copyright © 2020 Guihot, Litvinova, Autran, Debré and Vieillard.
Figures
Similar articles
-
World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26. Int J Surg. 2020. PMID: 32112977 Free PMC article. Review.
-
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.J Infect Public Health. 2020 Nov;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011. Epub 2020 Aug 4. J Infect Public Health. 2020. PMID: 32778421 Free PMC article.
-
Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.Eur J Immunol. 2020 Jul;50(7):932-938. doi: 10.1002/eji.202048693. Epub 2020 Jun 15. Eur J Immunol. 2020. PMID: 32438473 Free PMC article. Review.
-
Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.Pediatr Pulmonol. 2020 Jul;55(7):1584-1591. doi: 10.1002/ppul.24810. Epub 2020 Jun 1. Pediatr Pulmonol. 2020. PMID: 32483934 Free PMC article. Review.
-
Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.Rev Med Virol. 2020 May;30(3):e2107. doi: 10.1002/rmv.2107. Epub 2020 Apr 8. Rev Med Virol. 2020. PMID: 32267987 Free PMC article. Review.
Cited by
-
Omicron variant: Current insights and future directions.Microbiol Res. 2022 Dec;265:127204. doi: 10.1016/j.micres.2022.127204. Epub 2022 Sep 17. Microbiol Res. 2022. PMID: 36152612 Free PMC article. Review.
-
Tea Polyphenols Prevent and Intervene in COVID-19 through Intestinal Microbiota.Foods. 2022 Feb 10;11(4):506. doi: 10.3390/foods11040506. Foods. 2022. PMID: 35205982 Free PMC article. Review.
-
Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus.NPJ Vaccines. 2023 Jul 14;8(1):102. doi: 10.1038/s41541-023-00695-x. NPJ Vaccines. 2023. PMID: 37452052 Free PMC article.
-
Impaired anti-SARS-CoV-2 antibody response in non-severe COVID-19 patients with diabetes mellitus: A preliminary report.Diabetes Metab Syndr. 2021 Jan-Feb;15(1):193-196. doi: 10.1016/j.dsx.2020.12.035. Epub 2020 Dec 25. Diabetes Metab Syndr. 2021. PMID: 33385765 Free PMC article.
-
Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.Front Immunol. 2021 May 26;12:665329. doi: 10.3389/fimmu.2021.665329. eCollection 2021. Front Immunol. 2021. PMID: 34122423 Free PMC article.
References
-
- World Health Organization Considerations in Adjusting Public Health and Social Measures in the Context of COVID-19: Interim Guidance, 16 April 2020. (2020) Available online at: https://apps.who.int/iris/handle/10665/331773
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous